Deep learning predicts the 1-year prognosis of pancreatic cancer patients using positive peritoneal washing cytology.

Journal: Scientific reports
PMID:

Abstract

Peritoneal washing cytology (CY) in patients with pancreatic cancer is mainly used for staging; however, it may also be used to evaluate the intraperitoneal status to predict a more accurate prognosis. Here, we investigated the potential of deep learning of CY specimen images for predicting the 1-year prognosis of pancreatic cancer in CY-positive patients. CY specimens from 88 patients with prognostic information were retrospectively analyzed. CY specimens scanned by the whole slide imaging device were segmented and subjected to deep learning with a Vision Transformer (ViT) and a Convolutional Neural Network (CNN). The results indicated that ViT and CNN predicted the 1-year prognosis from scanned images with accuracies of 0.8056 and 0.8009 in the area under the curve of the receiver operating characteristic curves, respectively. Patients predicted to survive 1 year or more by ViT showed significantly longer survivals by Kaplan-Meier analyses. The cell nuclei found to have a negative prognostic impact by ViT appeared to be neutrophils. Our results indicate that AI-mediated analysis of CY specimens can successfully predict the 1-year prognosis of patients with pancreatic cancer positive for CY. Intraperitoneal neutrophils may be a novel prognostic marker and therapeutic target for CY-positive patients with pancreatic cancer.

Authors

  • Aya Noguchi
    Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
  • Yasushi Numata
    Pathology Informatics Team, RIKEN Center for Advanced Intelligence Project, Tokyo 103-0027, Japan. yasushi.numata@riken.jp.
  • Takanori Sugawara
    Department of Pathology, Tohoku University Hospital, Sendai, 980-8574, Japan.
  • Hiroshu Miura
    Department of Pathology, Tohoku University Hospital, Sendai, 980-8574, Japan.
  • Kaori Konno
    Department of Pathology, Tohoku University Hospital, Sendai, 980-8574, Japan.
  • Yuzu Adachi
    Department of Pathology, Tohoku University Hospital, Sendai, 980-8574, Japan.
  • Ruri Yamaguchi
    Pathology Informatics Team, RIKEN Center for Advanced Intelligence Project, Tokyo, 103-0027, Japan.
  • Masaharu Ishida
    Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
  • Takashi Kokumai
    Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
  • Daisuke Douchi
    Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
  • Takayuki Miura
    Department of Radiology Services, Gifu University Hospital, Gifu, Japan.
  • Kyohei Ariake
    Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
  • Shun Nakayama
    Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
  • Shimpei Maeda
    Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
  • Hideo Ohtsuka
    Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
  • Masamichi Mizuma
    Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
  • Kei Nakagawa
    Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
  • Hiromu Morikawa
    Pathology Informatics Team, RIKEN Center for Advanced Intelligence Project, Tokyo 103-0027, Japan. hiromu.morikawa@riken.jp.
  • Jun Akatsuka
    Pathology Informatics Team, RIKEN Center for Advanced Intelligence Project, Tokyo 103-0027, Japan. jun.akatsuka@riken.jp.
  • Ichiro Maeda
    Pathology Informatics Team, RIKEN Center for Advanced Intelligence Project, Tokyo 103-0027, Japan. ichiro@insti.kitasato-u.ac.jp.
  • Michiaki Unno
    Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Yoichiro Yamamoto
    Department of Pathology, Shinshu University School of Medicine, Nagano, Japan.
  • Toru Furukawa
    Department of Investigative Pathology, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.